SEOUL -South Korea on Friday authorized the use of SKYCovione, a homegrown COVID-19 vaccine developed by SK Bioscience Co., for booster shots against the coronavirus in addition to its use as primary inoculations.

The decision was announced by Second Vice Health Minister Lee Ki-il at the meeting of the government’s Central Disaster and Safety Countermeasure Headquarters.

Hospitals and clinics will be allowed to administer SKYCovione vaccines as third and fourth inoculations from Sept. 26.